Clinic
Levelup MD Urgent Care NJ LLC
Levelup MD Urgent Care NJ LLC was paid $261K by Medicaid between Sep 2022 and Mar 2024, across 21 billing codes. Its largest line is 99203, doctor's office visit, new patient (routine) — 24% of everything it billed.
33Billing provider infoLEVELUP MD URGENT CARE NJ LLC
EMERSON, NJ 07630
EMERSON, NJ 07630
33aNPI1144967753assigned 05/16/2022
33bProvider typeUrgent Care Clinic/Center
28Total paid$261K
24GClaims7,026
24DCodes billed21
24AFirst – last monthSep 2022 – Mar 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in New Jersey
Rank by total paid#30 of 60
Median peer was paid$255K
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 924 | $37K | |
| 2023 | 6,011 | $220K | |
| 2024incomplete | 91 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 24% | 1,101 | 1,003 | $63K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 16% | 597 | 544 | $41K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 459 | 410 | $32K |
| S9083 | Global fee urgent care centers | 12% | 436 | 397 | $32K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 467 | 413 | $27K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 8.7% | 1,047 | 896 | $23K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 7.1% | 180 | 153 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.9% | 974 | 553 | $8K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.0% | 53 | 45 | $5K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 634 | 568 | $4K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 58 | 52 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 52 | 48 | $2K |
9 more codes
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 44 | $1K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 16 | $446.70 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 14 | $300.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $126.90 |
| 81025 | <1% | 47 | $105.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 16 | $62.88 |
| 99051 | <1% | 763 | $24.14 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 14 | $0.00 |
| 81000 | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGAMSS, JONATHAN (MD)
| Provider | Location | Paid |
|---|---|---|
| Vladimir Zelenko M.D. P.C. | Monroe, NY | $10.95M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.